Resources

Resources to Get You Started

Find the Nearest Apheresis Center With Spectra Optia

Webinars

Plasma Exchange: Multiple Venous Access Versus Peripheral Access?

Hear from professor Dr. Kurt Derfler as he shares his extensive experience with plasma exchange using peripheral access.

Implementing Peripheral Venous Access Using Ultrasound Guidance

Hear from Anna-Marie Eller Thomsen as she shares her experience in implementing an ultrasound-guided peripheral vascular access program and how the program has impacted patients and nurses.

Brochures

Video

How Plasma Exchange Works on Spectra Optia

Watch

Spectra Optia Apheresis System Intended Use

The Spectra Optia Apheresis System, a blood component separator, may be used to perform the following therapeutic apheresis, cell collection, and cell processing procedures: Therapeutic plasma exchange; red blood cell exchange, depletion, and depletion/exchange for the transfusion management of sickle cell disease in adults and children; mononuclear cell collection from the peripheral blood; granulocyte collection from the peripheral blood; white blood cell reduction for patients with leukocytosis at risk for leukostasis; and processing of harvested bone marrow for the purpose of facilitating hematopoietic reconstitution.

Apheresis-Related Safety Information

Contraindications

Contraindications for the use of Spectra Optia are limited to those associated with the infusion of solutions and replacement fluids as required by the apheresis procedure and those associated with all types of automated apheresis systems.

Adverse events of apheresis procedures can include

Anxiety, headache, light-headedness, digital and/or facial paresthesia, fever, chills, hematoma, hyperventilation, nausea and vomiting, syncope (fainting), urticaria, hypotension, allergic reactions, infection, hemolysis, thrombosis in patient and device, hypocalcemia, hypokalemia, thrombocytopenia, hypoalbuminemia, anemia, coagulopathy, fatigue, hypomagnesemia, hypogammaglobulinemia, adverse tissue reaction, device failure/disposable set failure, air embolism, blood loss/anemia, electrical shock, fluid imbalance and inadequate separation of blood components.

Reactions to blood products transfused during procedures can include

Hemolytic transfusion reaction, immune-mediated platelet destruction, fever, allergic reactions, anaphylaxis, transfusion-related acute lung injury (TRALI), alloimmunization, posttransfusion purpura (PTP), transfusion-associated graft-versus-host disease (TA-GVHD), circulatory overload, hypothermia, metabolic complications and transmission of infectious diseases and bacteria.^1,2

Restricted to prescription use only

Operators must be familiar with the system's operating instructions
Procedures must be performed by qualified medical personnel.

¹AABB. Circular of Information for the Use of Human Blood and Blood Components. Bethesda, MD: AABB; 2017.

²European Directorate for the Quality of Medicines & HealthCare (EDQM). Guide to the Preparation, Use and Quality Assurance of Blood Components. 19th edition. Strasbourg, France: EDQM Council of Europe; 2017.

How Plasma Exchange Works on Spectra Optia

MG

GBS

How TPE Works

Safety

Cost

Resources

Webinars

Resources to Get You Started

FOR PRESCRIBERS

Find the Nearest Apheresis Center With Spectra Optia

Find

Webinars

ADVANCING APHERESIS IN NEUROLOGY: REVIEW OF NEUROLOGICAL DISEASE INDICATIONS FOR PLASMA EXCHANGE

Review the latest evidence-based guidelines at this on-demand webinar.

PLASMA EXCHANGE TREATMENT FOR MYASTHENIA GRAVIS

Hear from Dr. Demeret as she shares her extensive experience in using TPE to treat MG.

THERAPEUTIC PLASMA EXCHANGE IN GBS

Hear from Dr. Alqarni as she shares her experience with TPE for GBS.

PLASMA EXCHANGE: MULTIPLE VENOUS ACCESS VERSUS PERIPHERAL ACCESS?

Hear from professor Dr. Kurt Derfler as he shares his extensive experience with plasma exchange using peripheral access.

IMPLEMENTING PERIPHERAL VENOUS ACCESS USING ULTRASOUND GUIDANCE

Hear from Anna-Marie Eller Thomsen as she shares her experience in implementing an ultrasound-guided peripheral vascular access program and how the program has impacted patients and nurses.

Abstract Summaries

Intensive management and treatment of severe Guillain-Barrè syndrome

Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Crit Care Med. 1993;21(3):443-446.

Download

Plasma exchange for Guillain-Barré syndrome (review)

Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2017;2:CD001798.

Download

Safety of plasma exchange therapy in patients with myasthenia gravis

Ebadi H, Barth D, Bril V. Muscle Nerve. 2013;47(4):510-514.

Download

International consensus guidance for management of myasthenia gravis: Executive summary

Sanders DB, Wolfe GI, Benatar M, et al. Neurology. 2016;87(4): 419-425.

Download

Brochures

5 Myths of Plasma Exchange: An Immunomodulatory Therapy

Download

Plasma Exchange for GBS and MG Patients

Download

Guide: How to Order TPE

Download

Case Studies

UCSD Cost Analysis Case Study

Download

Video

How Plasma Exchange Works on Spectra Optia

Watch

FOR YOUR PATIENTS

TPE Patient Brochure

Download

Bulk Order for Your Practice

Apheresis-Related Safety Information

Contraindications

Leukocytapheresis is contraindicated in acute myeloid leukemia FAB M3 (acute promyelocytic leukemia) because of the accompanying disseminated intravascular coagulation.^1,2 Other contraindications for the use of the Spectra Optia system are limited to those associated with the infusion of solutions and replacement fluids as required by the apheresis procedure and those associated with all types of automated apheresis systems.

Adverse events of apheresis procedures can include

Reactions to blood products transfused during procedures can include

Restricted to prescription use only

Operators must be familiar with the system's operating instructions
Procedures must be performed by qualified medical personnel.

¹Vahdat L, Maslak P, Miller WH Jr, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform and CD13 expression in patients treated with all-trans retinoic acid. Blood. 1994;84(11):3843-3849.

²Daver N, Kantarjian H, Marcucci G, et al. Clinical characteristics and outcomes in patients with acute promyelotic leukaemia and hyperleucocytosis. Br J Haematol. 2015;168(5):646-653.

³AABB. Circular of Information for the Use of Human Blood and Blood Components. Bethesda, MD: AABB; 2017.

⁴European Directorate for the Quality of Medicines & HealthCare (EDQM). Guide to the Preparation, Use and Quality Assurance of Blood Components. 19th edition. Strasbourg, France: EDQM Council of Europe; 2017.

{{$index+1}}. {{s.label}}

Resources to Get You Started

Find the Nearest Apheresis Center With Spectra Optia

Plasma Exchange: Multiple Venous Access Versus Peripheral Access?

Implementing Peripheral Venous Access Using Ultrasound Guidance

5 Myths of Plasma Exchange

Guide: How to Order TPE

TPE Patient Brochure

How Plasma Exchange Works on Spectra Optia

How Plasma Exchange Works on Spectra Optia

MG

GBS

How TPE Works

Safety

Cost

Resources

Webinars

RESOURCES

Resources to Get You Started

FOR PRESCRIBERS

Find the Nearest Apheresis Center With Spectra Optia

ADVANCING APHERESIS IN NEUROLOGY: REVIEW OF NEUROLOGICAL DISEASE INDICATIONS FOR PLASMA EXCHANGE

PLASMA EXCHANGE TREATMENT FOR MYASTHENIA GRAVIS

THERAPEUTIC PLASMA EXCHANGE IN GBS

PLASMA EXCHANGE: MULTIPLE VENOUS ACCESS VERSUS PERIPHERAL ACCESS?

IMPLEMENTING PERIPHERAL VENOUS ACCESS USING ULTRASOUND GUIDANCE

Intensive management and treatment of severe Guillain-Barrè syndrome

Plasma exchange for Guillain-Barré syndrome (review)

Safety of plasma exchange therapy in patients with myasthenia gravis

International consensus guidance for management of myasthenia gravis: Executive summary

5 Myths of Plasma Exchange: An Immunomodulatory Therapy

Plasma Exchange for GBS and MG Patients

Guide: How to Order TPE

UCSD Cost Analysis Case Study

How Plasma Exchange Works on Spectra Optia

FOR YOUR PATIENTS

TPE Patient Brochure